Table 1. Characteristics of patients.
| All | No drug | SU | |
|---|---|---|---|
| n | 41 | 23 | 18 |
| Female (%) | 27.9 | 21.7 | 36.8 |
| Age (years) | 62.5 ± 8.1 | 59.1 ± 6.1 | 66.7 ± 8.0* |
| Duration (years) | 7.8 ± 7.4 | 5.3 ± 7.8 | 11.0 ± 6.1* |
| BMI (kg/m2) | 22.9 ± 2.8 | 22.9 ± 3.3 | 23.0 ± 2.4 |
| Systolic BP (mmHg) | 134.9 ± 22.0 | 128.0 ± 23.4 | 143.7 ± 18.5* |
| Diastolic BP (mmHg) | 79.4 ± 9.4 | 79.5 ± 9.7 | 79.3 ± 9.4 |
| HbA1c (%) | 7.1 ± 0.6 | 7.0 ± 0.5 | 7.3 ± 0.6 |
| Fasting plasma glucose (mg/dL) | 123.4 ± 21.2 | 121.3 ± 28.6 | 128.2 ± 13.6 |
| Fasting insulin (mU/L) | 5.1 ± 2.5 | 4.3 ± 3.2 | 6.0 ± 1.5* |
| Fasting CPR (ng/mL) | 1.5 ± 0.5 | 1.5 ± 0.5 | 1.6 ± 0.5 |
| Fasting glucagon (pg/mL) | 107.4 ± 33.7 | 107.1 ± 32.6 | 107.9 ± 35.3 |
| HOMA‐IR | 1.6 ± 0.8 | 1.3 ± 1.0 | 1.9 ± 0.5* |
| HOMA‐β | 33.1 ± 21.0 | 28.1 ± 20.8 | 40.0 ± 11.5* |
| SUIT | 42.2 ± 20.8 | 38.9 ± 25.2 | 46.3 ± 16.4 |
Each value represents the mean ± SD. All, both anti‐diabetic drug‐naïve patients and sulfonylureas‐treated patients; BMI, body mass index; BP, blood pressure; HOMA, homeostatic model assessment; IR, insulin resistance; No drug, anti‐diabetic drug‐naïve patients; SU, sulfonylureas‐treated patients; SUIT, secretory unit of islet in transplantation. *P < 0.05 (unpaired t‐test vs No drug).